DaVita healthCare Partners Inc Stock News

DaVita Inc. (NYSE:DVA ) Q3 2022 Earnings Conference Call October 28, 2022 8:30 AM ET Company Participants Javier Rodriguez - Chief Executive Officer Joel Ackerman - Chief Financial Officer Conference

Shares of DaVita Inc. plummeted in active trading Friday, toward their worst performance in more than two decades, after the dialysis company reported third-quarter that fell well below expectations a

DaVita's (DVA) Q3 performance gets a boost from strength in both its segments.

DaVita HealthCare (DVA) delivered earnings and revenue surprises of -12.12% and 1.08%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

High labor costs, along with inflationary pressures, are likely to have weighed on DaVita's (DVA) third quarter's top line.

Warren Buffet's philosophy relies on identifying stocks to buy and hold. He believes that the best names to buy and hold are those of undervalued companies that have high chances of being successful o

DENVER , Oct. 14, 2022 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Friday, October 28, 2022, at 8:30 a.

The Health Care sector has been a source of relative safety during this tumultuous September. While some large-caps in the space are catching bids, one smaller health care services and facilities comp

It's up for debate whether the stock market downturn has reached or is close to reaching the “bottoming out” stage, but there are many opportunities out there. While most of the best opportunities

These Berkshire Hathaway holdings sport forward-year price-to-earnings (P/E) ratios of 4.8 to 9.2.

Undervalued stocks are  businesses that trade below their intrinsic value.  Thomas Chua is the author of the 3-Bullet Sunday investment newsletter.

Warren Buffett loves to own cash-generating "toll bridge" companies. DaVita qualifies on both counts.

DaVita (DVA) records an overall solid Q2 performance owing to strength in its Other segment's revenues and uptick in total U.S. dialysis treatments.

DaVita Inc. (NYSE:DVA ) Q2 2022 Earnings Conference Call August 1, 2022 5:00 PM ET Corporate Participants Joel Ackerman - Chief Financial Officer and Treasurer Javier Rodriguez - Chief Executive Offic

DaVita HealthCare (DVA) delivered earnings and revenue surprises of 9% and 0.27%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?